7. What would be the change in clinical
trials?
• Phase 1 trials will be majorly lab based…
• larger samples of data even for very rare
disease occurrences…
• Number of subjects in phase 2 clinical trials
would be reduced…
• Better Safety, better results…
8. What would be the change in CDM?
• Phase 1 would have more of LABs data…
• eCRF will not be needed for Phase 1…
• Very less amendments/CRs…
• We might have to design the eCRF based on
the data base structure…
• Will have much more standardized the data
and validation/analysis will be much simpler
and easier…